domingo, 7 de junio de 2026
Orexina e hiperactivación en el TDM: una revisión rápida
https://www.medscape.org/viewarticle/orexin-and-hyperarousal-mdd-rapid-fire-review-2026a1000eyh?page=2&subtitle-lang-code=es
Orexin and Hyperarousal in MDD: A Rapid-Fire Review
Authors: Leslie Citrome, MD, MPH; Joseph Goldberg, MD
This activity includes discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario